NL-OMON20146已完成不适用
A double-blind, randomized, double dummy, cross over, study to assess the difference in efficacy between nebulisation of rhDNase in the morning versus nebulisation before going to sleep.
Roche Nederland BVPO Box 443440 AA WOERDENThe Netherlands0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
Eur Respir J. 2007 Oct;30(4):763-8. Epub 2007 Jun 27.
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Proven CF, as evidenced by an abnormal sweat test or an abnormal rectum potential difference measurement or by the presence of two CF mutations and at least one clinical feature of CF.
- •2. Treated at the Erasmus MC - Sophia, and
排除标准
- 未提供
研究者
相似试验
已完成
不适用
A double-blind, randomized, double dummy, cross over, study to assess the difference in efficacy between nebulisation of rhDNase before airway clearande therapy (ACT)versus nebulisation after ACT.Cysic Fibrosis.NL-OMON25167Roche Nederland BVPO box 443440 AA WOERDEN The Netherlands25
已完成
4 期
Evaluation of Lactosectan versus placebo to compare the effectiveness and safety in treating adult patients with intolerance to certain foods, primarily lactose intoleranceactose intoleranceNutritional, Metabolic, EndocrineLactose intoleranceISRCTN18410689ovintethical Pharma SA60
进行中（未招募）
不适用
A double-blind, randomised, multicenter, comparativestudy of escitalopram and duloxetine in outpatients withMajor Depressive DisorderEUCTR2004-005069-39-DEH. Lundbeck A/S260
进行中（未招募）
1 期
A double-blind, randomised, multicenter, comparativestudy of escitalopram and duloxetine in outpatients withMajor Depressive DisorderMajor depressive disorderEUCTR2004-005069-39-SEH. Lundbeck A/S260
进行中（未招募）
1 期
A double-blind, randomised, multicenter, comparative study of escitalopram and duloxetine in outpatients with Major Depressive DisorderMajor depressive disorderEUCTR2004-005069-39-CZH.Lundbeck A/S260